U.S. News

FDA Flags ‘Important Potential Risk’ in Pfizer’s RSV Vaccine

SAFETY STUDY

Two adults in their 60s were diagnosed with Guillain-Barre syndrome after getting the shot in a clinical trial.

2020-12-02T161636Z_66796950_RC24FK98GK8Z_RTRMADP_3_HEALTH-CORONAVIRUS-BRITAIN-PFIZER_wzxtbi
Reuters

Got a tip? Send it to The Daily Beast here.